2016
Natriuretic peptides in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction: A prospective observational cohort study
GANOVSKÁ, Eva, Mattia ARRIGO, Kateřina HELÁNOVÁ, Simona LITTNEROVÁ, Malha SADOUNE et. al.Základní údaje
Originální název
Natriuretic peptides in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction: A prospective observational cohort study
Autoři
GANOVSKÁ, Eva (703 Slovensko, domácí), Mattia ARRIGO (250 Francie), Kateřina HELÁNOVÁ (203 Česká republika, domácí), Simona LITTNEROVÁ (203 Česká republika, domácí), Malha SADOUNE (250 Francie), Petr KUBENA (203 Česká republika, domácí), Marie PAVLUŠOVÁ (203 Česká republika, domácí), Jiří JARKOVSKÝ (203 Česká republika, domácí), Jana GOTTWALDOVÁ (203 Česká republika, domácí), Petr KALA (203 Česká republika, domácí), Milan DASTYCH (203 Česká republika, domácí), Shiro ISHIHARA (250 Francie), Lucas N.L. VAN AELST (250 Francie), Alain COHEN-SOLAL (250 Francie), Etienne GAYAT (250 Francie), Jindřich ŠPINAR (203 Česká republika, domácí), Jiří PAŘENICA (203 Česká republika, domácí) a Alexandre MEBAZAA (250 Francie)
Vydání
International Journal of Cardiology, Clare (Ireland), Elsevier Ireland Ltd. 2016, 0167-5273
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 6.189
Kód RIV
RIV/00216224:14110/16:00090477
Organizační jednotka
Lékařská fakulta
UT WoS
000376297100115
Klíčová slova anglicky
Myocardial infarction; STEMI; Discharge; Zwolle; BNP
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 26. 4. 2017 12:05, Soňa Böhmová
Anotace
V originále
Background: The Zwolle score is recommended to identify low-risk patients eligible for early hospital discharge after ST-elevation myocardial infarction (STEMI), but since only one third of STEMI has low Zwolle score, hospital discharge is frequently delayed. B-type natriuretic peptide (BNP) also provides prognostic information after STEMI. The aim of the study was to test the hypothesis that patients with high Zwolle score associated with low BNP share similar outcomes than those with low Zwolle score. Methods and results: The study population consisted of 1032 consecutive STEMI patients in whom BNP was measured 24 h after chest pain onset. The area under the curve of Zwolle score and plasma BNP for 30-day mortality were 0.82 and 0.87, p = 0.39. A BNP threshold of 200 pg/ml had sensitivity of 100% and specificity of 34% for predicting 30-day mortality. Patients with high Zwolle score and BNP = 200 pg/ml (n = 183) had similar mortality and hospital stay to those with low Zwolle score (0% vs. 0.5% and 5 vs. 5 days, both p= 1.0). By contrast, patients with high Zwolle score and BNP > 200 pg/ml had the highest mortality (6.7%) and the longest hospital stay (6 days), both p < 0.01. Conclusion: STEMI patients with high Zwolle score but low BNP share similar outcomes with those with low Zwolle score and should be eligible for early discharge. Hence, using the rule of "low-Zwolle or low-BNP" might increase the number of STEMI patients that might be eligible for early discharge.
Návaznosti
MUNI/A/1362/2015, interní kód MU |
|